Drug solutions or vehicle of equal volume (1.5% DMSO in 10 ml aCSF) were superfused on the cortical surface free of dura in the rostral cranial window after taking DC potential and CBF baseline for 5 min under aCSF. Drug concentrations were carefully selected based on dose response curves, selectivity and efficacy reported previously14 (link)16 (link)18 (link)34 (link). The following drugs were applied topically: the selective COX-2 inhibitor NS-398 (100 μM; Cayman)16 (link), the selective COX-1 inhibitor SC-560 (25 μM; Cayman)22 (link), or the selective PGE2 receptor (EP4) antagonist L161,982 (1 μM; Sigma)14 (link)34 (link). The pharmacological treatment was initiated 40 min prior ischemia induction or the elicitation of the first SD event (i.e. sham-operated group)16 (link) and incubation persisted till the end of the experimental protocol.
Free full text: Click here